How to use the speech recognition tool?
A Post-Authorization, Multicenter, Multinational, Longitudinal,Observational Safety Registry Study for Patients Treated with Voretigene Neparvovec.
Status of the trial: Active, Not recruiting
Orphan Drug Recognition: No
Inclusion: Plan to receive or have received voretigen neparvovec in at least one eye.
Exclusion: Patient who did not receive voretigen neparvovec in at least one eye.
Funder Type: industry
Principal location of the trial
HCP: Principal investigators
HCP: Other investigators